Skip directly to Accessibility Notice

How to Purchase

BBH
VanEck Vectors Biotech ETF

Fund Description

VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

 
 

  • Fund Ticker

    BBH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    Bank of New York Mellon
  • Index Ticker

    MVBBHTR
  • Index Rebalancing

    Quarterly

 
as of 10/21/19

  • 30-Day SEC Yield1

    0.40%
  • Total Net Assets

    $328.6M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.40%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Annual
  • Next Distribution Date

    12/20/2019

Index Key Points

Underlying Index: MVIS US Listed Biotech 25 Index (MVBBHTR) 

The Index comprises:

U.S. exchange-listed companies that derive most of their revenues from bio-technology, including companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment

Companies initially eligible for inclusion in Index:

  • Principally engaged in the bio-technology industry, deriving greater than 50% of revenues from it
  • Full market capitalization exceeding $150 million
  • Three-month average-daily-trading volume of at least $1 million
  • At least 250,000 shares traded per month

Index provider:

MV Index Solutions 

Index Profile

  • Ticker

    MVBBHTR
  • Inception Date

    08/12/2011
  • Rebalance Frequency

    Quarterly

Index Top 10 Constituents (%) as of 09/30/19 Download All Index Constituents

Total Constituents: 25
Swipe
to view
full data
Constituent Name
Ticker
Weightings (%)
Amgen Inc
AMGN US
10.88
Gilead Sciences Inc
GILD US
7.32
Celgene Corp
CELG US
7.20
Illumina Inc
ILMN US
5.42
Allergan Plc
AGN US
5.34
Iqvia Holdings Inc
IQV US
5.14
Biogen Idec Inc
BIIB US
5.09
Vertex Pharmaceuticals Inc
VRTX US
5.02
Regeneron Pharmaceuticals
REGN US
4.53
Incyte Corp
INCY US
4.35
Top 10 Total (%) 60.29
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Index Country Weightings (%) as of 09/30/19

  • Country

    Weightings (%)
  • United States

    94.6
  • China

    2.7
  • Spain

    2.7
  • OTHERS

    0.0

Index Sector Weightings (%) as of 09/30/19

  • Sector

    Weightings (%)
  • Health Care

    100.0
  • OTHERS

    0.0